Posterior reversible encephalopathy syndrome following pembrolizumab therapy for relapsed Hodgkin’s lymphoma

Posterior reversible encephalopathy syndrome (PRES) is characterized by a group of central nervous system related symptoms. Diagnosis is usually made by computed tomography or magnetic resonance imaging. Common causes can be arterial hypertension, sepsis, autoimmune disorders, and medications. We re...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of oncology pharmacy practice 2017-01, Vol.23 (1), p.71-74
Hauptverfasser:	LaPorte, Justin, Solh, Melhem, Ouanounou, Serge
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Monoclonal, Humanized - therapeutic use Antineoplastic Agents - therapeutic use Female Hodgkin Disease - drug therapy Humans Posterior Leukoencephalopathy Syndrome - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!